Lunai Bioworks
@lunaibioworks.com
Decoding life. Delivering cures.
Press release: ir.lunaibioworks.com/news/news-de...
Lunai Bioworks (NASDAQ: LNAI) Highlights Drug Discovery and Biodefense AI Platform on CNBC
Lunai Bioworks (NASDAQ: LNAI), an AI-powered biotech and biodefense company, was featured on CNBC's Business Minute . Company CEO David Weinstein shared how the company is using its proprietary AI pla...
ir.lunaibioworks.com
February 13, 2026 at 7:31 PM
Press release: ir.lunaibioworks.com/news/news-de...
Learn more about Lunai Bioworks: www.lunaibioworks.com
LUNAI
Harnessing phenomics and AI to turn disease signals into new therapies. We uncover treatments by reading disease in motion, decoded by AI, confirmed in living systems, built for patients.
www.lunaibioworks.com
February 13, 2026 at 7:31 PM
Learn more about Lunai Bioworks: www.lunaibioworks.com
We’re focused on speed: get samples into the lab, identify what they are, and move toward countermeasures quickly while we work on longer-term solutions.
February 13, 2026 at 7:31 PM
We’re focused on speed: get samples into the lab, identify what they are, and move toward countermeasures quickly while we work on longer-term solutions.
In the segment, we highlighted Sentinel™, an AI safeguard designed to help prevent advanced models from generating harmful chemical compounds and reduce the risk of misuse as models become more capable.
February 13, 2026 at 7:31 PM
In the segment, we highlighted Sentinel™, an AI safeguard designed to help prevent advanced models from generating harmful chemical compounds and reduce the risk of misuse as models become more capable.
Press release: ir.lunaibioworks.com/news/news-de...
Lunai Bioworks (NASDAQ: LNAI) Launches AI Oncology Pilot with Clinical-Stage Partner to Analyze Randomized Phase 2 Metastatic Colorectal Cancer Survival Trial Data
, an AI-powered drug discovery and biodefense company, today announced the launch of a new oncology collaboration with a clinical-stage partner to analyze data from a randomized Phase 2 metastatic col...
ir.lunaibioworks.com
February 10, 2026 at 7:10 PM
Press release: ir.lunaibioworks.com/news/news-de...
Learn more about Lunai Bioworks: www.lunaibioworks.com
LUNAI
Harnessing phenomics and AI to turn disease signals into new therapies. We uncover treatments by reading disease in motion, decoded by AI, confirmed in living systems, built for patients.
www.lunaibioworks.com
February 10, 2026 at 7:10 PM
Learn more about Lunai Bioworks: www.lunaibioworks.com
Our goal is to identify biologically meaningful patient subgroups most likely to benefit, and generate data-driven enrichment strategies to strengthen future trial design.
February 10, 2026 at 7:10 PM
Our goal is to identify biologically meaningful patient subgroups most likely to benefit, and generate data-driven enrichment strategies to strengthen future trial design.
Using our Augusta AI platform, we’ll evaluate de-identified clinical, imaging, and longitudinal outcome data, focusing on overall survival and disease progression endpoints.
February 10, 2026 at 7:10 PM
Using our Augusta AI platform, we’ll evaluate de-identified clinical, imaging, and longitudinal outcome data, focusing on overall survival and disease progression endpoints.
Learn more about Lunai Bioworks: www.lunaibioworks.com
LUNAI
Harnessing phenomics and AI to turn disease signals into new therapies. We uncover treatments by reading disease in motion, decoded by AI, confirmed in living systems, built for patients.
www.lunaibioworks.com
February 9, 2026 at 6:19 PM
Learn more about Lunai Bioworks: www.lunaibioworks.com
Want to learn more about Augusta, phenomics, and Contingent AI? We’d love to chat.
February 9, 2026 at 6:19 PM
Want to learn more about Augusta, phenomics, and Contingent AI? We’d love to chat.
We’re excited to connect with teams working on lab automation, data-rich assays, and scalable discovery workflows.
February 9, 2026 at 6:19 PM
We’re excited to connect with teams working on lab automation, data-rich assays, and scalable discovery workflows.
Want to meet at SLAS? Use partneringONE (log in, then search “Lunai Bioworks”) to request a partnering meeting. Learn more: www.lunaibioworks.com.
LUNAI
Harnessing phenomics and AI to turn disease signals into new therapies. We uncover treatments by reading disease in motion, decoded by AI, confirmed in living systems, built for patients.
www.lunaibioworks.com
February 2, 2026 at 7:24 PM
Want to meet at SLAS? Use partneringONE (log in, then search “Lunai Bioworks”) to request a partnering meeting. Learn more: www.lunaibioworks.com.
We’ll be sharing more about Augusta, our phenomics capabilities, and Contingent AI, integrating genomic, proteomic, and phenotypic data to surface biomarkers and disease drivers across neurology, oncology, and biosecurity.
February 2, 2026 at 7:24 PM
We’ll be sharing more about Augusta, our phenomics capabilities, and Contingent AI, integrating genomic, proteomic, and phenotypic data to surface biomarkers and disease drivers across neurology, oncology, and biosecurity.
Read the press release to learn more: ir.lunaibioworks.com/news/news-de...
Lunai Bioworks (NASDAQ: LNAI) Launches Sentinel, an AI Safeguard to Block Large Language Models from Generating Novel Chemical Weapons
Transformer-based biosecurity layer embeds directly into foundation models, using Lunai's proprietary toxicology and in-vivo datasets to detect and prevent creation of previously unknown threat agents...
ir.lunaibioworks.com
January 27, 2026 at 6:33 PM
Read the press release to learn more: ir.lunaibioworks.com/news/news-de...
It’s backed by ~550 million public chemical structures and strengthened by proprietary toxicology and in vivo phenotypic datasets.
January 27, 2026 at 6:33 PM
It’s backed by ~550 million public chemical structures and strengthened by proprietary toxicology and in vivo phenotypic datasets.
Unlike basic keyword or rules-based checks, Sentinel is designed to identify latent risk in novel molecular structures, even when no public toxicity label exists.
January 27, 2026 at 6:33 PM
Unlike basic keyword or rules-based checks, Sentinel is designed to identify latent risk in novel molecular structures, even when no public toxicity label exists.
Sentinel screens molecular outputs in real time and can flag or block structures linked to hazardous mechanisms, including patterns consistent with known threat pathways.
January 27, 2026 at 6:33 PM
Sentinel screens molecular outputs in real time and can flag or block structures linked to hazardous mechanisms, including patterns consistent with known threat pathways.
Read the press release: ir.lunaibioworks.com/news/news-de...
Lunai Bioworks (NASDAQ: LNAI) Expands NIH-Funded AI Program into Commercial Alcohol Use Disorder Drug Discovery
Lunai Bioworks (NASDAQ: LNAI ), an AI-powered drug discovery and biodefense company, today announced it has completed a key commercial milestone under its NIH STTR-supported initiative, generating hi...
ir.lunaibioworks.com
January 26, 2026 at 7:43 PM
Read the press release: ir.lunaibioworks.com/news/news-de...
We identified distinct, reproducible neurobehavioral phenotypes that are only partially addressed by currently approved therapies, highlighting underexplored mechanisms with translational potential.
January 26, 2026 at 7:43 PM
We identified distinct, reproducible neurobehavioral phenotypes that are only partially addressed by currently approved therapies, highlighting underexplored mechanisms with translational potential.
Using high-throughput vertebrate screening, we generated high-resolution behavioral signatures of ethanol exposure and alcohol withdrawal.
January 26, 2026 at 7:43 PM
Using high-throughput vertebrate screening, we generated high-resolution behavioral signatures of ethanol exposure and alcohol withdrawal.